Oklo Inc (OKLO) Investment Analysis
1. Executive Summary
Oklo Inc. operates as an advanced nuclear technology company at the forefront of the commercial microreactor and small modular reactor (SMR) development space [cite: 1, 2]. The company is actively designing and deploying fast-fission power plants engineered to provide clean, reliable, and affordable baseload electricity and heat at a global scale [cite: 1, 2]. Oklo's business model is structurally distinct from traditional nuclear reactor vendors that sell hardware to third-party operators [cite: 2, 3]. Instead, the company implements a "power-as-a-service" framework, wherein it acts as the developer, owner, and operator of the power assets, monetizing its technology directly by selling electricity and heat to end-use customers through long-term, utility-style Power Purchase Agreements (PPAs) [cite: 2, 4].
In addition to its primary power-generation business, Oklo is executing a vertically integrated strategy encompassing two complementary, high-margin business lines: nuclear fuel recycling and fabrication, and commercial radioisotope production [cite: 5, 6]. These integrated units leverage shared nuclear capabilities, siting, licensing, and operational workflows to capture value across the entire atomic lifecycle [cite: 5, 6].
The company's primary target customers are hyperscale data center operators, remote industrial facilities (such as Permian Basin oil and gas operations), and defense or government installations that require reliable, continuous, emission-free electricity [cite: 7, 8, 9]. These customers increasingly choose Oklo over traditional grid-connected utility alternatives due to severe grid-interconnection delays, the high capital intensity of building dedicated grid-transmission infrastructure, and the operational necessity for always-on, non-intermittent carbon-free power [cite: 10, 11]. By offering on-site or localized microreactor deployments with zero upfront capital risk to the customer, Oklo provides clean energy security while de-risking its partners' operational growth profiles [cite: 12, 13].
Historically pre-revenue, the company transitioned to early commercialization in the second quarter of fiscal year 2026, generating its first-ever material top-line results through its isotopes business unit, specifically from operations at its Idaho Radiochemistry Laboratory [cite: 5, 14, 15, 16]. Geographically, the company's development pipeline is concentrated in the United States, with key projects located at the Idaho National Laboratory (INL), Pike County in southern Ohio, Lockhart in Caldwell County, Texas, and Eielson Air Force Base in Alaska [cite: 6, 17, 18, 19].
2. Business Drivers and Strategic Overview
Oklo's strategic and financial viability is anchored to key commercial assets, distinct regulatory pathways, and a specialized technology architecture [cite: 6]. To evaluate the firm's long-term economic prospects, it is necessary to examine its specific product offerings, competitive advantages, market addressability, and positioning relative to peers [cite: 2, 20].
Product and Service Architecture
Oklo's core hardware offering is the Aurora powerhouse product line, which is designed in modular configurations ranging from 15 megawatts electric (MWe) to 75 MWe [cite: 2, 8, 9]. Unlike conventional light-water reactors that operate under high pressures and require massive safety containment structures, the Aurora is a liquid-metal-cooled, metal-fueled fast reactor that operates at near-atmospheric pressures [cite: 20, 21]. The utilization of liquid-sodium cooling eliminates the risk of rapid coolant depressurization or catastrophic boil-off, enabling passive, inherent safety profiles where the reactor naturally shuts down without human or mechanical intervention in a thermal excursion event [cite: 21, 22]. Furthermore, the reactor utilizes high-assay low-enriched uranium (HALEU) and is capable of running on recycled nuclear waste, providing exceptionally long core lifespans and significantly reduced refueling frequencies [cite: 2, 23].
The company's commercialized offerings are structured across three mutually reinforcing segments:
| Business Line |
Core Product / Asset |
Commercialization Mechanism |
| Power Generation |
Aurora Powerhouses (15–75 MWe) [cite: 2, 9] |
Build-own-operate PPAs with 20-year terms [cite: 2, 4, 8]. |
| Fuel Services |
Advanced Fuel Center & Aurora Fuel Fabrication Facility (A3F) [cite: 6, 23] |
Processing EBR-II fuel into finished metallic rods; third-party recycled offtake [cite: 6, 23, 24]. |
| Isotope Production |
Idaho Radiochemistry Lab & Groves Isotope Test Reactor [cite: 15, 17, 25] |
Production of medical and space radioisotopes (e.g., Radium-226 feedstocks) [cite: 7, 15]. |
The Advanced Fuel Center and the A3F facility, both located at the INL site, are critical to ensuring the company’s fuel supply security [cite: 6, 23]. A3F utilizes feedstock from used EBR-II metallic uranium fuel to manufacture fuel assemblies for the first Aurora core, with commissioning and fuel rod production targeted for the late-2027 to early-2028 window [cite: 23, 24].
The radioisotopes division, managed through Atomic Alchemy, focuses on extracting high-value isotopes for healthcare, industrial, and space exploration applications [cite: 7, 17]. Atomic Alchemy’s Idaho facility operates under an NRC materials license that authorizes the handling of up to 2 Curies of Radium-226, enabling commercial sales of targeted alpha therapy feedstocks [cite: 15, 26]. The company plans to expand this division by constructing a multi-reactor "isotope foundry" consisting of up to four non-power Versatile Isotope Production Reactor (VIPR) systems [cite: 25, 27].
Competitive Advantages and Economic Moat Analysis
Oklo is building a multi-layered economic moat characterized by high customer switching costs, regulatory first-mover advantages, and vertical integration [cite: 6]:
- High Switching Costs: Because Oklo targets dedicated, on-site or localized power supply for massive, capital-intensive digital and industrial infrastructure, customers become physically and contractually locked into Oklo’s power supply [cite: 11]. The 20-year term of the typical PPA ensures that any attempt by a customer to transition to alternative power sources would incur severe capital losses, structural redesign costs, and operational downtime [cite: 8, 11].
- Regulatory First-Mover Advantages: Licensing a novel, non-light-water reactor design in the United States is a highly complex process [cite: 28, 29]. Having engaged with the NRC since 2016, Oklo was the first company to submit a custom combined license application (COLA) for an advanced reactor [cite: 1, 8]. While its initial application was denied without prejudice in 2022 due to technical information gaps [cite: 30, 31], the company has systematically addressed these concerns [cite: 30, 32]. In early 2026, the NRC approved Oklo’s Principal Design Criteria (PDC) topical report on an accelerated review schedule [cite: 33, 34]. This establishes a reusable regulatory framework that defines the safety requirements for all future Aurora designs, significantly reducing the timeline and duplication of reviews for subsequent COLAs [cite: 32, 34].
- Ecosystem and Vertical Integration Moat: By pairing its reactor deployment with proprietary fuel recycling (A3F) and radioisotope extraction (Atomic Alchemy), Oklo creates an "integrated nuclear flywheel" [cite: 5, 6]. This reduces dependence on external, geopolitically constrained HALEU enrichment sources and turns a regulatory liability (used nuclear fuel) into high-margin revenue streams [cite: 5, 6, 35].
- Proprietary Manufacturing Control: The strategic acquisitions of Creative Engineers, Inc. (CEI) and ARMEC in 1H 2026 bolster the moat by bringing specialized liquid-metal/sodium chemistry engineering and precision manufacturing capabilities in-house, mitigating supply chain vulnerabilities [cite: 12, 16].
Total Addressable Market and Pipeline
The global demand for clean, continuous baseload power is expanding rapidly, primarily driven by the computational demands of artificial intelligence and hyperscale cloud infrastructure [cite: 10, 11]. This computational infrastructure requires 24/7 power, a profile that wind and solar cannot satisfy without massive, economically unviable battery storage systems [cite: 11, 20].
Oklo’s addressable market is directly represented by its customer pipeline, which has expanded to approximately 14 GW of potential capacity [cite: 9, 36, 37].
| Customer / Partner |
Commitment Type |
Capacity / Scope |
Expected Timeline |
| Switch |
Non-binding Master Agreement [cite: 3] |
12 GW of modular capacity [cite: 3, 9] |
Deployments starting in 2029 [cite: 3] |
| Meta Platforms |
Binding Prepayment Agreement [cite: 19, 23] |
1.2 GW Clean Energy Campus [cite: 13, 19] |
Site work in 2026; online in 2030 [cite: 19, 38] |
| Equinix |
Letter of Intent (LOI) [cite: 36] |
500 MW of power [cite: 8, 36] |
Sequential deployment phase [cite: 3, 13] |
| Diamondback Energy |
Letter of Intent (LOI) [cite: 8] |
50 MW (Permian Basin operations) [cite: 8] |
20-year operational term [cite: 8] |
Furthermore, the domestic medical isotope market represents a multi-billion-dollar market opportunity with severe structural supply constraints, as the United States currently lacks robust domestic production of isotopes like Actinium-225 and Radium-226, relying heavily on foreign imports [cite: 26, 39].
Competitive Landscape and Positioning
Oklo competes within the small modular and microreactor market against several notable advanced nuclear developers [cite: 2, 32]. While NuScale possesses a regulatory head start with its light-water certification [cite: 32], its technology is highly capital-intensive, requiring multi-billion-dollar investments and massive civil construction work [cite: 20]. Oklo’s smaller 15–75 MWe footprint allows for factory-assembled, transportable units that align with modular data hall architectures, avoiding the first-of-a-kind (FOAK) construction cost overruns that historically plague larger utility-scale builds [cite: 8, 9, 22].
TerraPower is positioned for utility-scale baseload grid injection [cite: 20], whereas Oklo is targeting the off-grid and direct industrial colocation market, giving it an operational edge in terms of speed-to-market and deployment flexibility [cite: 2, 12]. The company is actively gaining ground, as evidenced by its rapid progress at the Groves Isotope Test Reactor in Texas, which achieved first criticality in less than a year from breaking ground [cite: 14, 40].
3. Financial Performance and Valuation
A evaluation of Oklo's financial structure indicates a pre-commercial business transitioning toward early-stage execution [cite: 7]. The capital requirements of nuclear development necessitate a detailed analysis of the company's latest quarterly results, liquidity runway, spending guidance, and valuation parameters [cite: 5, 7, 41].
Latest Quarterly Financial Performance
Oklo reported its second-quarter 2026 financial results on August 7, 2026, marking a significant transition from a purely pre-revenue development vehicle to an active operating business [cite: 5, 16]:
- First-Ever Revenue Generation: Oklo recorded its first-ever material quarterly revenue of \$1.21 million [cite: 14, 42]. This result significantly exceeded the consensus Wall Street estimate of approximately \$83,800 to \$90,000, representing a substantial surprise driven by early radioisotope sales and radiochemistry services via its Idaho Falls facility [cite: 5, 12, 14].
- Net Loss and EPS Performance: The GAAP net loss for the quarter widened to \$48.54 million, compared to a net loss of \$24.7 million in Q2 2025 [cite: 16, 43]. On a per-share basis, the adjusted loss came in at \$0.28, missing the analyst expectation of a -\$0.16 loss per share by \$0.12 [cite: 5, 12, 43]. This widening loss was driven by a sharp escalation in operating expenses as the company scaled its advanced fission ecosystem [cite: 16].
- Operating Expense Escalation: Total research and development (R&D) expenses climbed to \$39.47 million, up from \$11.5 million in the prior-year quarter, and above the Bloomberg consensus estimate of \$23.3 million [cite: 43]. This increase reflects accelerated engineering, licensing, and prototyping activities [cite: 7, 41, 44]. General and administrative (G&A) expenses also grew to \$34.21 million for the quarter [cite: 16].
- Balance Sheet and Capital Reserves: As of June 30, 2026, Oklo’s cash, cash equivalents, and marketable debt securities totaled \$3.01 billion, up from \$1.25 billion at year-end 2025 [cite: 7, 16, 45]. This growth was driven primarily by at-the-market (ATM) equity offerings during the first half of 2026, which issued 23.1 million shares and raised net proceeds of \$1.85 billion [cite: 5, 16]. Total stockholders' equity grew to \$3.27 billion as of June 30, 2026 [cite: 45].
- Upward Spending Guidance Revision: Management raised its full-year 2026 financial spending guidance to reflect accelerated project timelines [cite: 5, 12]. Operating cash use is now expected to range from \$120 million to \$150 million (up from the prior estimate of \$80 million to \$100 million) [cite: 5, 12]. Capital expenditures (property, plant, and equipment) are now projected at \$400 million to \$500 million, compared to the previous guidance of \$350 million to \$450 million [cite: 5, 12].
Management Commentary and Market Impact
During the earnings call, management highlighted that Oklo’s core strategy relies on treating its power, fuel recycling, and isotope units as one integrated nuclear platform rather than three separate businesses [cite: 5]. Jacob DeWitte, Co-Founder and CEO, emphasized the achievement of first criticality at the Groves Isotope Test Reactor in Lockhart, Texas, on August 5, 2026, as concrete proof that the industry can execute reactor construction and startup on timelines measured in months rather than years under integrated pilot programs [cite: 1, 40].
The combination of the revenue beat and the Texas reactor criticality milestone served as a powerful positive catalyst for the stock [cite: 14]. Shares rose 7.63% to close at \$45.41 on the day of the presentation, with intraday price action surging past its opening of \$44.39 to a high of \$48.81 on high volume [cite: 5, 14]. Following the release, analysts maintained a consensus "Buy" rating, with average brokerage recommendations of 1.96 on a scale of 1 to 5, and average 12-month target prices ranging from \$84.20 to \$86.83 [cite: 46, 47, 48].
Underlying Financial Drivers of Valuation
Traditional near-term valuation multiples (such as Enterprise Value to EBITDA or trailing P/E) are not applicable to Oklo due to its current pre-profitability status and minimal initial revenues [cite: 4, 49]. Instead, the long-term valuation is driven by structural inputs:
- Capacity Deployment and PPA Tariffs: The core driver of Oklo's terminal value is the volume of operational megawatt capacity and the average realized tariff per megawatt-hour (MWh) [cite: 12, 50]. The US nuclear industry has average historical generation costs of approximately \$33.74/MWh [cite: 51], while first-of-a-kind (FOAK) advanced modular reactor levelized costs of electricity (LCOE) are estimated between \$90/MWh and \$160/MWh [cite: 20]. Long-term PPA tariffs are expected to settle near a premium rate of \$80 to \$100/MWh for high-reliability, carbon-free baseload power delivered directly off-grid to hyperscalers [cite: 11, 20].
- Five-Year Sales Growth Model: Consensus estimates forecast a rapid scaling phase from 2026 through 2031 [cite: 52, 53]. After a projected FY 2026 revenue of \$1.8 million and FY 2027 revenue of \$8.3 million [cite: 53], sales growth is assumed to expand at a CAGR exceeding 100% over the next five years [cite: 52]. This hyper-growth phase is supported by the planned commercialization of the 75 MWe Aurora-INL plant by late 2027/early 2028 [cite: 9, 23], followed by initial power deliveries from the 1.2 GW Meta Ohio campus around 2030 [cite: 19, 23].
- Vertical Integration Margin Expansion: The integration of isotope sales (via Atomic Alchemy) and proprietary fuel recycling is a key driver for margin expansion [cite: 5, 6]. Commercial isotope operations are highly complementary, asset-light, and carry gross margins estimated near 60%, providing positive cash flow to offset the high capital expenditures associated with core powerhouse construction [cite: 12, 40].
4. Risk Assessment and Macroeconomic Considerations
Investing in advanced nuclear technology involves navigating a highly complex, capital-intensive ecosystem [cite: 29]. A rigorous assessment requires categorizing company-specific execution, regulatory, supply chain, and macroeconomic risks, and distinguishing their long-term impact on the core investment thesis [cite: 7, 29, 45].
Execution and Technological Risks
The primary execution risk is first-of-a-kind (FOAK) engineering and construction delays [cite: 20]. While liquid-sodium fast-reactor technology has been demonstrated historically (e.g., the EBR-II operated from 1964 to 1994) [cite: 8, 23], it has never been licensed and operated at commercial scale under modern private development structures in the United States [cite: 20, 28]. Reactor scaling from 50 MWe to 75 MWe could introduce structural or thermal anomalies that require design modifications [cite: 9].
- What could go wrong: Mechanical or structural failure in liquid-sodium pumps or primary heat-pipe systems during commissioning at the Idaho site [cite: 2, 9, 30].
- Early Warning Sign: Delays in critical component deliveries from in-house manufacturing units (ARMEC or CEI), or failure to pass non-nuclear thermal testing targeted for 2027 [cite: 16, 23].
- Most Damage to Thesis: A major cooling system or structural failure during hot functional testing that forces a complete core redesign, delaying commercialization by years and destroying investor confidence in fast-fission passive safety [cite: 2, 9].
Regulatory and Licensing Risks
The NRC licensing process remains a critical barrier to commercialization [cite: 28, 29]. Oklo’s regulatory pathway is non-standard [cite: 32]. While it utilizes a performance-based licensing methodology (PBLM) and generic topical reports to accelerate approval [cite: 30, 32], any safety concerns raised by the NRC staff regarding core physics, sodium chemistry, or accident propagation (Maximum Credible Accident analysis) can halt progress [cite: 30, 31].
- What could go wrong: The NRC rejects or indefinitely delays Oklo's custom COLA submission for the Aurora-INL or Aurora-Ohio sites [cite: 9, 31].
- Early Warning Sign: The NRC staff issues extensive Requests for Additional Information (RAIs) regarding maximum credible accidents or QA program implementation, replicating the issues that led to the 2022 license denial [cite: 31, 54].
- Most Damage to Thesis: A permanent rejection or structural regulatory halt to the licensing of the liquid-metal fast reactor design in the United States, rendering the core power business unviable [cite: 31, 55].
Customer Concentration and Demand Realization Risks
Oklo's paper-based backlog is highly concentrated [cite: 49, 56]. While the company boasts an impressive ~14 GW pipeline, this is dominated by a single, non-binding 12 GW Master Power Agreement with Switch [cite: 3, 9]. If these early-stage Letters of Intent (LOIs) and Memorandums of Understanding (MOUs) fail to convert into legally binding, definitive PPAs, the long-term revenue model is severely compromised [cite: 3, 49].
- What could go wrong: Key customers experience localized regulatory roadblocks or grid-interconnection refusals in PJM, forcing cancellation [cite: 10, 57].
- Early Warning Sign: Inability to transition the non-binding agreements with Switch or Equinix into definitive, binding contracts within the next 12 to 18 months [cite: 3, 8].
- Most Damage to Thesis: Meta cancels its 1.2 GW southern Ohio Clean Energy Campus project due to structural grid constraints or strategic shifts in its capital allocation, resulting in the loss of its largest committed anchor tenant [cite: 11, 19].
Supply Chain and Fuel Bottlenecks
Advanced reactors require HALEU fuel, enriched to between 5% and 20% Uranium-235 [cite: 35, 58]. Currently, global commercial HALEU enrichment capacity is highly constrained, with historical reliance on Russian and Chinese state entities [cite: 35]. While Oklo has secured an LOI with Centrus Energy to supply HALEU from its Piketon, Ohio centrifuge facility [cite: 21, 23], Centrus is still expanding its industrial buildout and is subject to strict federal funding and licensing limits [cite: 57, 59].
- What could go wrong: Centrus fails to deliver commercially enriched HALEU within the scheduled 2029 window [cite: 21, 23].
- Early Warning Sign: Regulatory delays in Centrus's centrifuge facility licensing or failure to transition the LOI into a definitive supply contract [cite: 21, 23].
- Most Damage to Thesis: A structural domestic HALEU supply shortage that prevents Oklo from procuring initial core loads for its powerhouses, leaving completed reactors unable to start up [cite: 23, 45].
Balance Sheet, Dilution, and Capital Allocation Risks
Although Oklo currently has a robust \$3.01 billion liquidity position [cite: 5, 16], the capital expenditure requirements to construct multiple gigawatts of reactor capacity under a build-own-operate model are extremely high [cite: 2, 12]. The company expects to burn through up to \$500 million in CapEx in 2026 alone [cite: 5, 12]. If operations are delayed, Oklo will be forced to continuously raise capital, either through dilutive at-the-market (ATM) equity programs or high-yield debt issuance, diluting existing shareholders [cite: 49, 58].
- What could go wrong: Continued project delays force successive dilutive capital raises under depressed stock valuations [cite: 49, 58].
- Early Warning Sign: Filing of additional multi-billion-dollar shelf registrations or ATM programs that outpace tangible reactor construction progress [cite: 58, 60].
- Most Damage to Thesis: Structural dilution that expands the outstanding share count from ~185 million to over 400 million, permanently depressing per-share earnings power even after reactors become operational [cite: 45].
Macroeconomic Sensitivities
Nuclear energy projects are capital-intensive clean technologies highly sensitive to global macroeconomic shifts [cite: 29]. Elevated interest rates directly inflate the weighted average cost of capital (WACC), driving up the financing costs of reactor fabrication and making nuclear-generated power less competitive against subsidized renewable alternatives [cite: 20, 29]. Furthermore, inflation in key commodity markets—such as structural steel, concrete, specialized metal alloys, and liquid sodium—directly increases the capital cost per installed kilowatt, pushing back the breakeven timeline [cite: 12, 29].
5. 5-Year Scenario Analysis
To evaluate Oklo's potential financial and equity value trajectory over a 5-year investment horizon (extending to FY 2031), this analysis models three distinct operating scenarios [cite: 52, 53]. The valuation model assumes a current spot share price of \$49.36 [cite: 61] and an initial outstanding share count of 185.09 million Class A common shares [cite: 45].
Operational Valuation Mechanics
For a capital-intensive utility and technology play in a hyper-growth phase, Enterprise Value (EV) and Equity Value are modeled using a forward Price-to-Sales ($P/S$) multiple [cite: 49, 53]. To connect the financial results directly to the core operational model, Year 5 electricity revenue is projected based on deployed megawatt capacity [cite: 6]. Let $E$ be the annual energy generation in MWh, calculated as:
$E = P \times H \times CF$
where $P$ is the deployed powerhouse capacity in MW [cite: 9], $H$ is the total hours in a year ($8,760$), and $CF$ is the expected capacity factor ($90\%$) [cite: 50]. Applying an assumed long-term electricity PPA tariff ($T$) of \$80 per MWh [cite: 20]:
$\text{Annual Power Revenue} = E \times T$
For example, a standard 75 MW Aurora powerhouse [cite: 9] operating under these parameters generates:
$E = 75 \times 8760 \times 0.90 = 591,300 \text{ MWh}$
$\text{Annual Power Revenue} = 591,300 \times 80 = \$47,304,000$
High Case (25% Probability)
This scenario assumes flawless operational, regulatory, and commercial execution [cite: 6, 7]. The NRC approves COLAs for the Aurora-INL reactor and the initial phase of the Aurora-Ohio campus on accelerated timelines [cite: 9, 32].
- Operational & Capacity Metrics: Total deployed operational capacity reaches 600 MW by Year 5 [cite: 9]. This includes the 75 MW Aurora-INL plant [cite: 9], the 5 MW Eielson AFB microreactor [cite: 6], and the first 520 MW phase of the Meta Pike County Clean Energy Campus [cite: 19, 62]. Additionally, Atomic Alchemy’s radioisotope foundry is fully operational, generating high-margin medical and space isotope revenues [cite: 25, 40].
- Financial Assumptions: Year 5 consolidated revenue reaches \$550 million, consisting of \$378 million in power-generation revenues and \$172 million in high-margin radioisotope and recycled fuel fabrication revenues [cite: 5, 40]. Operating and net margins scale to 20% due to favorable pricing power under premium PPAs and high-margin isotope distribution [cite: 11, 40], yielding a Year 5 net income of \$110 million.
- Capital & Share Count Structure: Total outstanding shares are capped at 200 million [cite: 45], as capital expenditure is funded primarily through non-dilutive customer prepayments from Meta and project-specific, non-recourse debt [cite: 13, 19].
- Valuation Multiple: A high growth premium is maintained, resulting in an exit $P/S$ multiple of 60.0x [cite: 53].
- Projected Outcome: Total future equity value is \$33.0 billion (\$550 million revenue $\times$ 60.0x P/S). The projected Year 5 share price is $165.00 USD [cite: 45]. This implies a total 5-year return of +234.3%, translating to an annualized return of +27.3%.
Base Case (50% Probability)
This scenario assumes moderate regulatory delays and standard engineering execution timelines [cite: 7, 63].
- Operational & Capacity Metrics: Total deployed operational capacity reaches 230 MW by Year 5 [cite: 6]. The 75 MW Aurora-INL reactor is online [cite: 9], alongside the 5 MW Eielson AFB unit [cite: 6], and the initial 150 MW phase of the Meta campus [cite: 19, 23]. Isotope operations are active but scaling gradually from the Radiochemistry Laboratory [cite: 12, 15].
- Financial Assumptions: Year 5 consolidated revenue reaches \$200 million, with power generation contributing \$145 million and isotope/fuel services contributing \$55 million [cite: 6, 12]. Net income remains at a slight GAAP loss of -\$20 million (operating margin of -10%) due to ongoing R&D and construction costs for the remaining meta campus phases [cite: 5, 7].
- Capital & Share Count Structure: Outstanding shares increase to 220 million due to moderate utilization of ATM equity programs to fund capex over the next 3 to 4 years [cite: 5, 58].
- Valuation Multiple: The market applies a standard advanced utility growth premium, resulting in an exit $P/S$ multiple of 45.0x [cite: 53].
- Projected Outcome: Total future equity value is \$9.0 billion (\$200 million revenue $\times$ 45.0x P/S). The projected Year 5 share price is $40.91 USD [cite: 45]. This implies a total 5-year return of -17.1%, translating to an annualized return of -3.7%.
Low Case (25% Probability)
This scenario assumes extensive regulatory bottlenecks, high capital cost inflation, and failure to convert major pipeline prospects [cite: 7, 29].
- Operational & Capacity Metrics: Total deployed operational capacity is capped at 50 MW by Year 5, as the Aurora-INL project faces severe construction delays and the Meta Ohio campus project is deferred [cite: 7, 9, 11]. Only a small pool-type isotope test reactor is operational [cite: 40, 64].
- Financial Assumptions: Year 5 consolidated revenue is limited to \$40 million [cite: 53]. Due to high fixed operational costs, ongoing regulatory overhead, and high interest expenses, the net loss remains deep at -\$120 million (net margin of -300%) [cite: 5, 29].
- Capital & Share Count Structure: Total outstanding shares expand to 250 million, driven by heavy reliance on dilutive ATM equity issuances to fund ongoing cash burn [cite: 49, 58].
- Valuation Multiple: Market enthusiasm evaporates, and the exit $P/S$ multiple compresses to a conservative utility-equipment multiple of 15.0x [cite: 53].
- Projected Outcome: Total future equity value is \$600 million (\$40 million revenue $\times$ 15.0x P/S). The projected Year 5 share price is $2.40 USD [cite: 45]. This implies a total 5-year return of -95.1%, translating to an annualized return of -45.4%.
Implied Valuation and Share Price Trajectory
The model maps the projected trajectory of Oklo’s share price across all three scenarios over the next five years:
| Scenario |
Year 1 (FY 2027) |
Year 2 (FY 2028) |
Year 3 (FY 2029) |
Year 4 (FY 2030) |
Year 5 (FY 2031) |
| High Case [cite: 7] |
\$60.00 |
\$85.00 |
\$115.00 |
\$140.00 |
\$165.00 |
| Base Case [cite: 63] |
\$45.00 |
\$42.00 |
\$40.00 |
\$39.00 |
\$40.91 |
| Low Case [cite: 7] |
\$25.00 |
\$15.00 |
\$8.00 |
\$4.00 |
\$2.40 |
| Weighted Target |
$43.75 |
$46.00 |
$50.75 |
$55.50 |
$62.31 |
Scenario Summary Matrix
The quantitative parameters, valuation assumptions, and implied returns for each scenario are synthesized below:
| Scenario |
Revenue / key scale metric in Year 5 |
Margin / earnings assumption |
Valuation multiple assumption |
Current share price |
Implied future share price |
5-year total return |
Annualized return |
Probability |
| High Case [cite: 7] |
\$550 Million / 600 MW Deployed [cite: 9] |
20% Net Margin / \$110M Net Income [cite: 40] |
60.0x P/S [cite: 53] |
\$49.36 [cite: 61] |
\$165.00 [cite: 45] |
+234.3% |
+27.3% |
25% |
| Base Case [cite: 63] |
\$200 Million / 230 MW Deployed [cite: 6] |
-10% Op Margin / -\$20M Net Income [cite: 5] |
45.0x P/S [cite: 53] |
\$49.36 [cite: 61] |
\$40.91 [cite: 45] |
-17.1% |
-3.7% |
50% |
| Low Case [cite: 7] |
\$40 Million / 50 MW Deployed [cite: 7, 9] |
-300% Net Margin / -\$120M Net Income [cite: 5] |
15.0x P/S [cite: 53] |
\$49.36 [cite: 61] |
\$2.40 [cite: 45] |
-95.1% |
-45.4% |
25% |
The probability-weighted target share price is:
$\text{Target Share Price} = (0.25 \times \$165.00) + (0.50 \times \$40.91) + (0.25 \times \$2.40) = \$62.31 \text{ USD}$
This probability-weighted share price target implies a 5-year total return of +26.2% from the current spot price, translating to a +4.8% annualized return.
ASYMMETRIC GROWTH OPTION
6. Qualitative Scorecard
To evaluate the operational quality and fundamental risks of Oklo, the company is graded on ten key performance dimensions [cite: 7, 53]. This scorecard does not constitute financial advice or an investment recommendation.
Management Alignment: 8 / 10
The co-founders, Jacob DeWitte (CEO) and Caroline Cochran (COO), retain substantial equity ownership in the company, holding approximately 11.79% (or 20.51 million Class A shares) each [cite: 65]. This high insider ownership ensures that their long-term interests are closely aligned with those of outside shareholders [cite: 65]. Compensation policies are standard, with base salaries of \$400,000 to \$500,000 paired with performance-based RSU awards and discretionary bonuses [cite: 66, 67]. However, alignment is slightly offset by continuous, systematic insider selling under Rule 10b5-1 plans and Form 144 filings over the past several quarters [cite: 16, 68]. For instance, on August 3, 2026, insiders filed to sell up to 400,000 shares [cite: 68, 69]. Additionally, Sam Altman, who co-founded the AltC SPAC that brought Oklo public and holds a 3.82% stake, stepped down as chairman in April 2025 to avoid conflicts of interest with OpenAI [cite: 70, 71].
Revenue Quality: 4 / 10
While Oklo showed positive momentum in Q2 2026 by reporting its first-ever material quarterly revenue of \$1.21 million [cite: 14, 42], the overall quality of its revenue remains low [cite: 53]. The current top-line contribution is derived from early-stage isotope processing and consulting services rather than utility-scale baseload power sales [cite: 12, 42]. The core long-term revenue model—20-year utility PPAs—is highly stable and predictable [cite: 8, 11]. However, because the company remains years away from operational commercial reactors, the near-term revenue base is highly speculative and subject to significant timing volatility [cite: 4, 72].
Market Position: 7 / 10
Oklo is positioning itself as a leader in the commercial microreactor and advanced SMR segment [cite: 2, 56]. Its 14 GW customer pipeline, including massive commitments with Switch and Meta, represents some of the largest advanced nuclear agreements in corporate history [cite: 3, 9]. Despite this strong demand profile, the market position is currently non-binding, and Oklo must compete against established utility operators and capital-rich developers like TerraPower [cite: 3, 13].
Growth Outlook: 9 / 10
The secular growth outlook for clean baseload power is exceptionally strong [cite: 10, 11]. The exponential expansion of AI computing clusters and the direct commitment of hyperscalers to fund off-grid and grid-support nuclear capacity provide a virtually unlimited demand backdrop for Oklo's modular powerhouses [cite: 8, 10, 11].
Financial Health: 8 / 10
Oklo possesses outstanding near-term balance sheet strength [cite: 5, 16]. Its \$3.01 billion liquidity reserve (consisting of \$1.66 billion in cash and equivalents and \$1.35 billion in marketable debt securities) is superior to that of almost all its pre-revenue nuclear peers [cite: 5, 16, 42]. Its current ratio of 59.93 and net tangible book value of \$2.6 billion offer a robust buffer [cite: 16, 58, 73]. Nonetheless, the score is balanced at an 8 due to the high and rising cash burn associated with multi-asset civil construction [cite: 5, 7].
Business Viability: 5 / 10
The long-term durability of the business model faces high friction points [cite: 7]. Licensing novel liquid-metal designs with the NRC is structurally complex and carries significant scheduling uncertainty [cite: 28, 29]. Furthermore, securing domestic fuel supplies (HALEU) is a major industry-wide bottleneck [cite: 35, 57]. While Oklo is mitigating these constraints through its integrated fuel recycling (A3F) strategy, the commercial viability of its fast-reactor technology remains unproven at scale [cite: 20, 23].
Capital Allocation: 6 / 10
Management has executed several prudent capital moves, capitalizing on elevated share prices in 1H 2026 to secure \$1.85 billion in flexible funding via ATM equity offerings [cite: 5, 16]. Strategic acquisitions like CEI and ARMEC for \$33.38 million in aggregate strengthen critical engineering capabilities [cite: 12, 16]. However, the upward revision of 2026 CapEx and operating cash spend guidance suggests that project deployment is becoming more capital-intensive than initially modeled [cite: 5, 12].
Analyst Sentiment: 8 / 10
Sell-side sentiment is highly optimistic [cite: 35, 47]. The consensus rating is a "Buy," supported by an ABR of 1.96 from 23 brokerage firms [cite: 32, 48]. Average price targets settle near \$84 to \$86, representing a massive premium to the current spot price [cite: 46, 47, 48].
Profitability: 2 / 10
The company is fundamentally unprofitable, with trailing-twelve-month GAAP losses widening as R&D and administrative costs scale up [cite: 16, 43, 53]. The net loss of \$48.54 million in Q2 2026 indicates that operating profitability is a long-term goal that will not be achieved until several Aurora powerhouses are online [cite: 12, 16].
Track Record: 3 / 10
Having become a public company in May 2024 via a SPAC merger, Oklo has a very limited operating history [cite: 7, 71]. It has no track record of generating sustained operating cash flows or commercializing a power reactor [cite: 41, 53]. While its initial NRC license application was denied in 2022 [cite: 31, 55], the rapid 11-month construction and startup of the low-power Groves Isotope Test Reactor to criticality demonstrates execution capability [cite: 1, 40].
Qualitative Assessment and Score
A mathematical synthesis of these individual scores yields an overall qualitative rating:
$\text{Overall Blended Score} = \frac{8+4+7+9+8+5+6+8+2+3}{10} = 6.0 / 10$
This blended rating of 6.0 out of 10 reflects a company with strong near-term liquidity and massive market demand, balanced by substantial long-term regulatory, technological, and execution challenges inherent to advanced nuclear development [cite: 2, 5, 29].
SPECULATIVE TRANSITION STAGE
7. Conclusion and Investment Thesis
Oklo Inc. represents a highly speculative, high-barrier-to-entry play on the convergence of the artificial intelligence infrastructure buildout, the decarbonization of industrial power, and the revitalization of the domestic advanced nuclear supply chain [cite: 2, 10, 57]. The core investment thesis is built on the company's vertically integrated, power-as-a-service model, which aims to bypass the capital limitations of traditional utility models by offering factory-assembled, modular 15–75 MWe reactors directly to hyperscalers with zero upfront customer capital risk [cite: 2, 3, 9, 12].
The company's recent Q2 2026 financial and business update provides the first tangible proof of operational progress [cite: 5, 14]. The print of \$1.21 million in initial revenue, combined with the achievement of first criticality at the Groves Isotope Test Reactor in Texas in less than a year from groundbreaking, de-risks the company's execution timeline and establishes a repeatable deployment template [cite: 14, 40, 42, 74]. This operational momentum, paired with a massive \$3.01 billion liquidity buffer and a 14 GW customer pipeline, positions Oklo with a capital runway that few advanced nuclear developers can match [cite: 5, 9, 16].
Nonetheless, significant execution and regulatory friction points remain [cite: 7, 35]. The company is structurally unprofitable, with GAAP losses widening as project spend accelerates [cite: 16, 43, 53]. Its commercial-scale Aurora powerhouses have yet to secure construction permits or COLAs from the NRC [cite: 28, 35]. Furthermore, its massive pipeline consists almost entirely of non-binding LOIs, and any delays in commercializing its Idaho fuel fabrication facility or securing HALEU feedstock from Centrus could delay the timeline for first commercial power [cite: 3, 23, 49].
Future equity returns will be determined by three key catalysts:
1. The NRC's issuance of the draft Safety Evaluation for Oklo's Principal Design Criteria, which will solidify the licensing pathway [cite: 34, 75].
2. The formal submission and acceptance of the COLA for the Aurora-INL plant, targeted for commercial operation in late 2027 or early 2028 [cite: 9, 23, 54].
3. The conversion of non-binding LOIs with Switch and Equinix into definitive, binding PPAs with committed tariff rates [cite: 3, 8].
This investment profile is framed as a high-risk, high-reward technology transition play, rather than a mature utility investment. No recommendation or advice is provided.
EXECUTION-DRIVEN RERATING
8. Technical Analysis, Price Action and Short-Term Outlook
Oklo’s recent technical chart structure reflects a volatile trading environment, with the stock stabilizing near \$49.36 following its Q2 2026 earnings announcement [cite: 14, 61]. The stock is trading below its declining 200-day simple moving average, which is positioned between \$45.00 and \$82.37 depending on the exact historical timeframe evaluated, indicating a long-term bearish structure but showing signs of a near-term bullish reversal [cite: 28, 76]. The options market implies a high degree of volatility, with an implied volatility (IV) of 98.7% and a put-call volume ratio of 0.71, indicating a prevailing bullish bias among derivative traders following the Texas reactor milestone and the Q2 revenue beat [cite: 14, 77, 78]. In the short term, the stock's momentum is expected to remain highly sensitive to broader AI infrastructure capital flows, interest rate expectations, and federal announcements regarding domestic advanced nuclear initiatives [cite: 41, 76, 79].
MOMENTUM BOTTOMING OUT
- Oklo's Groves Reactor Achieves First Criticality in Under a Year, https://oklo.com/newsroom/news-details/2026/Oklos-Groves-Reactor-Achieves-First-Criticality-in-Under-a-Year/default.aspx
- Oklo Inc. (OKLO): +6% Gain in 30 Days Amid AI Partnerships and Nuclear Progress, https://tickeron.com/blogs/oklo-inc-oklo-6-gain-in-30-days-amid-ai-partnerships-and-nuclear-progress-13468/
- Oklo inks 12-GW advanced reactor supply agreement with data center developer Switch, https://www.utilitydive.com/news/oklo-aurora-smr-advanced-nuclear-reactor-supply-agreement-data-center-developer-switch/735933/
- What's Happening With Oklo Stock? - Trefis, https://www.trefis.com/stock/oklo/articles/572218/whats-happening-with-oklo-stock/2025-08-14
- Oklo Q2 2026 slides: first criticality achieved, $3B liquidity - Investing.com, https://www.investing.com/news/company-news/oklo-q2-2026-slides-first-criticality-achieved-3b-liquidity-93CH-4846923
- Company Update, https://s203.q4cdn.com/103172959/files/doc_financials/2026/q2/FINAL-DRAFT-2Q-2026-Company-Update-Deck.pdf
- Earnings call transcript: Oklo Inc. reports Q1 2026 results, shares drop, https://au.investing.com/news/stock-market-news/earnings-call-transcript-oklo-inc-reports-q1-2026-results-shares-drop-93CH-4429245
- Oklo's microreactor project pipeline jumps 93% ahead of 2027 planned deployment, https://www.utilitydive.com/news/oklo-advanced-nuclear-microreactor-project-pipeline-nrc/724343/
- Oklo reveals 75-MW reactor design, eyes late 2027 commercial deployment | Utility Dive, https://www.utilitydive.com/news/oklo-75-mw-reactor-design-smr-nuclear/743578/
- Oklo and Meta Plan 1.2 GW Advanced Nuclear Campus - Converge Digest, https://convergedigest.com/oklo-and-meta-plan-1-2-gw-advanced-nuclear-campus/
- Why Tech Giants Are Going Nuclear — The AI Power Crisis Driving Trillion-Dollar Energy Deals - SoftwareSeni, https://www.softwareseni.com/why-tech-giants-are-going-nuclear-the-ai-power-crisis-driving-trillion-dollar-energy-deals/
- Oklo Q2 2026 Earnings Report - MarketBeat, https://www.marketbeat.com/earnings/reports/2026-8-7-oklo-inc-stock/
- Meta Platforms Unveils Series of Nuclear Power Agreements, https://www.publicpower.org/periodical/article/meta-platforms-unveils-series-nuclear-power-agreements
- Oklo Inc Stock Price Today | NYSE: OKLO Live - Investing.com, https://www.investing.com/equities/altc-acquisition
- Oklo's Atomic Alchemy Granted U.S. Nuclear Regulatory Commission License for Isotope Material, https://oklo.com/newsroom/news-details/2026/Oklos-Atomic-Alchemy-Granted-U-S--Nuclear-Regulatory-Commission-License-for-Isotope-Material/default.aspx
- OKLO SEC Filings - Oklo Inc. 10-K, 10-Q, 8-K Forms - Stock Titan, https://www.stocktitan.net/sec-filings/OKLO/
- Oklo's Isotope Test Reactor achieves criticality - American Nuclear Society, https://www.ans.org/news/article-8277/oklos-isotope-test-reactor-achieves-criticality/
- US test reactors achieve milestones - World Nuclear News, https://world-nuclear-news.org/articles/us-test-reactors-achieve-milestones
- Energy - Ohio - Oklo Inc., https://oklo.com/energy/Ohio/default.aspx
- America's SMR Moment, Part I: Oklo, Global Competition, and the Hard Math Behind the Next Nuclear Buildout - Oil & Gas 360, https://www.oilandgas360.com/americas-smr-moment-part-i-oklo-global-competition-and-the-hard-math-behind-the-next-nuclear-buildout/
- Oklo, Centrus Sign Letter of Intent to Purchase Nuclear Fuel for Aurora Powerhouse Deployment in Southern Ohio - PR Newswire, https://www.prnewswire.com/news-releases/oklo-centrus-sign-letter-of-intent-to-purchase-nuclear-fuel-for-aurora-powerhouse-deployment-in-southern-ohio-302804265.html
- Upon the completion of this offering, outstanding shares of Class B common stock will represent, and Thomas Hendrix, our Founder, Chair of our board of - SEC.gov, https://www.sec.gov/Archives/edgar/data/2086716/000121390026078747/ea0276071-13.htm
- America just cleared a sodium-cooled reactor to start building that will run on uranium pulled from a reactor shut down in 1994, fuel older than half the company building it, a machine small enough to truck to a data center that can also run on other reactors' waste - Autonocion.com, https://www.autonocion.com/us/america-sodium-cooled-reactor/
- Oklo Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of Aurora Powerhouse at Idaho National Laboratory, https://oklo.com/newsroom/news-details/2026/Oklo-Announces-U-S--Department-of-Energy-Approval-for-Nuclear-Safety-Design-Agreement-of-Aurora-Powerhouse-at-Idaho-National-Laboratory/default.aspx
- Licensing of Oklo pilot reactor facilities advances - World Nuclear News, https://www.world-nuclear-news.org/articles/licensing-of-oklo-pilot-reactor-facilities-advances
- Oklo NRC License Paves Way For Isotope Sales | InsiderFinance, https://www.insiderfinance.io/news/oklo-nrc-license-paves-way-for-isotope-sales-earnings
- Oklo's Atomic Alchemy Granted U.S. Nuclear Regulatory Commission License for Isotope Material - Reddit, https://www.reddit.com/r/nuclear/comments/1rw890m/oklos_atomic_alchemy_granted_us_nuclear/
- OKLO Technical Analysis, RSI and Moving Averages - Investing.com, https://www.investing.com/equities/altc-acquisition-technical
- Advanced Nuclear Energy Is In Trouble | The Breakthrough Institute, https://thebreakthrough.org/blog/advanced-nuclear-energy-is-in-trouble
- NRC rejects Oklo application. Thoughts? : r/nuclear - Reddit, https://www.reddit.com/r/nuclear/comments/ry32hf/nrc_rejects_oklo_application_thoughts/
- Oklo Power LLC, a subsidiary of Oklo Inc.; Oklo Aurora Combined License Application Idaho National Laboratory - Federal Register, https://www.federalregister.gov/documents/2022/01/11/2022-00339/oklo-power-llc-a-subsidiary-of-oklo-inc-oklo-aurora-combined-license-application-idaho-national
- OKLO's Licensing Strategy Aims to Support Reactor Rollout - TradingView, https://www.tradingview.com/news/zacks:0ed07d3a4094b:0-oklo-s-licensing-strategy-aims-to-support-reactor-rollout/
- Oklo's NRC Principal Design Criteria Topical Report Approved for Aurora Powerhouse in Idaho, https://oklo.com/newsroom/news-details/2026/Oklos-NRC-Principal-Design-Criteria-Topical-Report-Approved-for-Aurora-Powerhouse-in-Idaho/default.aspx
- Oklo's NRC Principal Design Criteria Topical Report Accepted for Review Under an Accelerated Timeline, https://oklo.com/newsroom/news-details/2025/Oklos-NRC-Principal-Design-Criteria-Topical-Report-Accepted-for-Review-Under-an-Accelerated-Timeline/default.aspx
- Oklo Inc (OKLO) Stock Forecast: Analyst Ratings, Predictions & Price Target 2026, https://public.com/stocks/oklo/forecast-price-target
- 47 Drill Holes. 27000 Feet. One of the Largest Uranium Deposits in America. And an Integrated Nuclear Platform with Both the Fuel and Reactor technology. - Fidelity Investments, https://www.fidelity.com/news/article/default/202604090900PRIMZONEFULLFEED9686846
- OKLO Surges 33% in a Week on Space Power Catalyst: Buy Now? - April 20, 2026, https://www.zacks.com/stock/news/2903305/oklo-surges-33-in-a-week-on-space-power-catalyst-buy-now
- Oklo, Meta Announce Agreement in Support of 1.2 GW Nuclear Energy Development in Southern Ohio, https://oklo.com/newsroom/news-details/2026/Oklo-Meta-Announce-Agreement-in-Support-of-1-2-GW-Nuclear-Energy-Development-in-Southern-Ohio/default.aspx
- Isotopes - Texas - Oklo Inc., https://oklo.com/isotopes/texas/default.aspx
- Oklo's Groves Reactor Just Achieved First Criticality. Here's What It Means for OKLO Stock., https://www.fool.com/investing/2026/08/07/oklos-groves-reactor-just-achieved-first-criticality-heres-what-it-means-for-oklo-stock/
- Oklo Inc. Q1 2026 Earnings: EPS Beat Amid Pre-Revenue Nuclear Development, https://support.trustwave.com/expert-time/Oklo-Inc-Q1-2026-Earnings-EPS-Beat-Amid-PreRevenue-Nuclear-Development-43-19269
- Oklo Inc. (OKLO) first-ever quarterly revenue of $1.21 million (vs. $0.12 million consensus); EPS: -$0.28 (vs. -$0.16 expected) : r/stocks - Reddit, https://www.reddit.com/r/stocks/comments/1vi2843/oklo_inc_oklo_firstever_quarterly_revenue_of_121/
- Oklo reports wider Q2 loss despite revenue beat - Investing.com, https://www.investing.com/news/stock-market-news/oklo-reports-wider-q2-loss-despite-revenue-beat-93CH-4846061
- Oklo Inc. (OKLO) Q1 2026 Earnings: EPS Beat Amid Pre‑Revenue Phase; Shares Dip - Quarterly Profit Report, https://support.levelblue.com/first-dry/Oklo-Inc-OKLO-Q1-2026-Earnings-EPS-Beat-Amid-PreRevenue-Phase-Shares-Dip-47-14855
- Oklo Inc. - Cloudfront.net, https://d18rn0p25nwr6d.cloudfront.net/CIK-0001849056/45165f42-8ac0-49c0-a240-d2db60d05de8.pdf
- Oklo (NYSE:OKLO) Stock Valuation, Peer Comparison & Price Targets - Simply Wall St, https://simplywall.st/stocks/us/utilities/nyse-oklo/oklo/valuation
- Oklo Inc (OKLO) Stock Forecast & Price Target - Investing.com, https://www.investing.com/equities/altc-acquisition-consensus-estimates
- What is the current Price Target and Forecast for Oklo Inc. (OKLO) - Zacks Investment Research, https://www.zacks.com/stock/research/OKLO/price-target-stock-forecast
- Oklo Is Still Down 33% This Year. What Will It Take to Get OKLO Stock Back to $100?, https://247wallst.com/investing/2026/08/07/oklo-is-still-down-33-this-year-what-will-it-take-to-get-oklo-stock-back-to-100/
- Confidential Letter of Intent to Purchase Power, dated as of February 16, 2024, by and between Oklo Inc. and Equinix - SEC.gov, https://www.sec.gov/Archives/edgar/data/1849056/000110465924047344/tm2324337d21_ex10-19.htm
- Nuclear Power in the USA, https://world-nuclear.org/information-library/country-profiles/countries-t-z/usa-nuclear-power
- 15 AI Stocks Set for Triple-Digit Growth by 2030 - Tickeron, https://tickeron.com/trading-investing-101/the-5year-revenue-explosion-forecast-15-stocks-targeting-tripledigit-growth-by-2030/
- Oklo (OKLO) | Trefis, https://www.trefis.com/data/companies/OKLO
- Oklo Engaging with U.S. Nuclear Regulatory Commission in Pre-Application Readiness Assessment, https://oklo.com/newsroom/news-details/2025/Oklo-Engaging-with-U-S--Nuclear-Regulatory-Commission-in-Pre-Application-Readiness-Assessment/default.aspx
- Nuclear startup Oklo splits its first atoms in test reactor - Canary Media, https://www.canarymedia.com/articles/nuclear/nuclear-startup-oklo-splits-its-first-atoms-in-test-reactor
- OKLO Stock Extends Run As DOE Backs First Reactors - Timothy Sykes, https://timothysykes.com/news/oklo-inc-oklo-news-2026_04_23/
- Oklo's Ohio fuel deal brings advanced nuclear a step closer to reality - Ohio Tech News, https://www.ohiotechnews.com/oklo-ohio-fuel-deal-advanced-nuclear-step-closer-reality/
- Oklo files $1.0B ATM shelf to sell common stock | OKLO Prospectus Summary - Stock Titan, https://www.stocktitan.net/sec-filings/OKLO/424b5-oklo-inc-prospectus-supplement-debt-securities-7a856bb25a56.html
- Centrus Reports Second Quarter 2026 Results - Finviz, https://finviz.com/news/378074/centrus-reports-second-quarter-2026-results
- Oklo (OKLO) Investor Relations, Earnings Summary & Outlook - Quartr, https://quartr.com/companies/oklo-inc_15051
- OKLO Stock Price Quote & News - Robinhood, https://robinhood.com/us/en/stocks/OKLO/
- Beyond the Hype: Assessing Hyperscaler Nuclear Commitments Against U.S. Energy Realities | Carnegie Endowment for International Peace, https://carnegieendowment.org/research/2026/06/beyond-the-hype-assessing-hyperscaler-nuclear-commitments-against-us-energy-realities
- Oklo (NYSE:OKLO) - Earnings & Revenue Performance - Simply Wall St, https://simplywall.st/stocks/us/utilities/nyse-oklo/oklo/past
- Oklo's Groves Reactor Achieves First Criticality in Under a Year : r/nuclear - Reddit, https://www.reddit.com/r/nuclear/comments/1vh2sig/oklos_groves_reactor_achieves_first_criticality/
- Oklo Stock Ownership - Who Owns Oklo in 2026? - WallStreetZen, https://www.wallstreetzen.com/stocks/us/nyse/oklo/ownership
- Employment Agreement between Oklo Inc. and Craig Bealmear (Chief | AltC Acquisition Corp. | Business Contracts | Justia, https://contracts.justia.com/companies/altc-acquisition-corp-12473/contract/1284474/
- Employment Agreement between Oklo Inc. and Jacob DeWitte (Chief | AltC Acquisition Corp. | Business Contracts | Justia, https://contracts.justia.com/companies/altc-acquisition-corp-12473/contract/1284472/
- Oklo insiders plan sale of 400,000 Class A shares | OKLO SEC Filing - Form 144, https://www.stocktitan.net/sec-filings/OKLO/144-oklo-inc-sec-filing-1f7e9e9794f8.html
- Oklo insiders plan Rule 144 sale of 400000 shares | OKLO SEC Filing - Stock Titan, https://www.stocktitan.net/sec-filings/OKLO/144-oklo-inc-sec-filing-19e1c92ffd21.html
- Oklo Inc - Major Shareholders & Institutional Holdings - TradingKey, https://www.tradingkey.com/markets/stocks/oklo/ownership
- Sam Altman - Wikipedia, https://en.wikipedia.org/wiki/Sam_Altman
- OKLO Price: Quote, Forecast, Charts & News - Perplexity, https://www.perplexity.ai/finance/OKLO/earnings
- OKLO Stock Price Quote | Morningstar, https://www.morningstar.com/stocks/xmex/oklo/quote
- Oklo's Groves Reactor Achieves First Criticality in Under a Year - Investing News Network, https://investingnews.com/oklo-s-groves-reactor-achieves-first-criticality-in-under-a-year/
- NRC Targeting March 20, 2026 for Oklo PDC Draft Safety Evaluation - Reddit, https://www.reddit.com/r/OKLOSTOCK/comments/1re2txh/nrc_targeting_march_20_2026_for_oklo_pdc_draft/
- Why Oklo Inc. (OKLO) Stock Is Down -20.3% in the Last 30 Days - Tickeron, https://tickeron.com/ticker/OKLO/
- OKLO Expected Move for Oklo Stock - Barchart.com, https://www.barchart.com/stocks/quotes/OKLO/expected-move
- OKLO Put/Call Ratio for Oklo Stock - Barchart.com, https://www.barchart.com/stocks/quotes/OKLO/put-call-ratios
- Oklo Inc. Stock Price: Quote, Forecast, Splits & News (OKLO) - Perplexity, https://www.perplexity.ai/finance/OKLO?comparing=OKLO,CCJ,NPWR,RR.L,BE,VWS.CO